Viewing Study NCT00903656


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-01-10 @ 9:42 AM
Study NCT ID: NCT00903656
Status: TERMINATED
Last Update Posted: 2013-12-24
First Post: 2009-05-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None metastatic breast cancer View
None Her2 View
None Lapatinib View
None Caelyx View
None cardiotoxic View